[1] World Health Organization. Disease burden and mortality estimates: Cause-specific mortality, 2000−2016. Geneva: World Health Organization; 2018. https://www.who.int/healthinfo/global_burden_disease/estimates/en.https://www.who.int/healthinfo/global_burden_disease/estimates/en
[2] Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 2016;134(6):441 − 50. http://dx.doi.org/10.1161/CIRCULATIONAHA.115.018912CrossRef
[3] Wang ZW, Chen Z, Zhang LF, Wang X, Hao G, Zhang ZG, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012–2015. Circulation 2018;137(22):2344 − 56. http://dx.doi.org/10.1161/CIRCULATIONAHA.117.032380CrossRef
[4] Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA 2017;317(2):165 − 82. http://dx.doi.org/10.1001/jama.2016.19043CrossRef
[5] Padwal RS, Bienek A, McAlister FA, Campbell NR, Outcomes Research Task Force of the Canadian Hypertension Education Program. Epidemiology of hypertension in Canada: an update. Can J Cardiol 2016;32(5):687 − 94. http://dx.doi.org/10.1016/j.cjca.2015.07.734CrossRef
[6] World Health Organization. Hypertension care in Thailand: best practices and challenges, 2019. https://apps.who.int/iris/handle/10665/330488. [2020–9–20].https://apps.who.int/iris/handle/10665/330488
[7] Kontis V, Cobb LK, Mathers CD, Frieden TR, Ezzati M, Danaei G. Three public health interventions could save 94 million lives in 25 years. Circulation 2019;140(9):715 − 25. http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038160CrossRef
[8] Farley TA, Dalal MA, Mostashari F, Frieden TR. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med 2010;38(6):600 − 9. http://dx.doi.org/10.1016/j.amepre.2010.02.016CrossRef
[9] Ide N, Ajenikoko A, Steele L, Cohn J, Cohn CJ, Frieden TR, et al. Priority actions to advance population sodium reduction. Nutrients 2020;12(9):2543. http://dx.doi.org/10.3390/nu12092543CrossRef
[10] Frieden TR, Cobb LK, Leidig RC, Mehta S, Kass D. Reducing premature mortality from cardiovascular and other non-communicable diseases by one third: achieving Sustainable Development Goal indicator 3.4.1. Glob Heart 2020;15(1):50. http://dx.doi.org/10.5334/gh.531CrossRef
[11] National Health Commission of the People’s Republic of China. Healthy China Action Plan (2019-2030): campaign to prevent disease and promote health. National Health Commission of the People’s Republic of China. http://en.nhc.gov.cn/HealthyChinaActionPlan.html. [2020–9–20].http://en.nhc.gov.cn/HealthyChinaActionPlan.html
[12] Frieden TR, Jaffe MG. Saving 100 million lives by improving global treatment of hypertension and reducing cardiovascular disease risk factors. J Clin Hypertens 2018;20(2):208 − 11. http://dx.doi.org/10.1111/jch.13195CrossRef
[13] World Health Organization. HEARTS: Technical package for cardiovascular disease management in primary health care. Geneva: World Health Organization; 2016. http://www.who.int/cardiovascular_diseases/hearts/en.[2020–9–20].http://www.who.int/cardiovascular_diseases/hearts/en
[14] The World Bank and World Health Organization. Deepening health reform in China building high-quality and value-based service delivery. New York: The World Bank and World Health Organization, 2019. http://documents1.worldbank.org/curated/en/690791553844042874/pdf/Building-High-Quality-and-Value-Based-Service-Delivery.pdf. [2020–9–20].http://documents1.worldbank.org/curated/en/690791553844042874/pdf/Building-High-Quality-and-Value-Based-Service-Delivery.pdf
[15] Yip W, Fu HQ, Chen AT, Zhai TM, Jian WY, Xu RM, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet 2019;394(10204):1192 − 204. http://dx.doi.org/10.1016/S0140-6736(19)32136-1CrossRef
[16] He FJ, Brinsden HC, MacGregor GA. Salt reduction in the United Kingdom: a successful experiment in public health. J Hum Hypertens 2014;28(6):345 − 52. http://dx.doi.org/10.1038/jhh.2013.105CrossRef
[17] Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis 2006;49(2):59 − 75. http://dx.doi.org/10.1016/j.pcad.2006.07.001CrossRef
[18] Park HK, Lee Y, Kang BW, Kwon KI, Kim JW, Kwon S, et al. Progress on sodium reduction in South Korea. BMJ Glob Health 2020;5(5):e002028. http://dx.doi.org/10.1136/bmjgh-2019-002028CrossRef
[19] Du SF, Wang HJ, Zhang B, Popkin BM. Dietary potassium intake remains low and sodium intake remains high, and most sodium is derived from home food preparation for Chinese adults, 1991–2015 trends. J Nutr 2020;150(5):1230 − 9. http://dx.doi.org/10.1093/jn/nxz332CrossRef
[20] Xu AQ, Ma JX, Guo XL, Wang LH, Wu J, Zhang JY, et al. Association of a province-wide intervention with salt intake and hypertension in Shandong Province, China, 2011−2016. JAMA Intern Med 2020;180(6):877 − 86. http://dx.doi.org/10.1001/jamainternmed.2020.0904CrossRef
[21] Taillie LS, Reyes M, Colchero MA, Popkin B, Corvalán C. An evaluation of Chile’s Law of Food Labeling and Advertising on sugar-sweetened beverage purchases from 2015 to 2017: a before-and-after study. PLoS Med 2020;17(2):e1003015. http://dx.doi.org/10.1371/journal.pmed.1003015CrossRef
[22] Niebylski ML, Lu T, Campbell NR, Arcand J, Schermel A, Hua DE, et al. Healthy food procurement policies and their impact. Int J Environ Res Public Health 2014;11(3):2608 − 27. http://dx.doi.org/10.3390/ijerph110302608CrossRef
[23] Ma LY, Chen WW, Gao RL, Liu LS, Zhu ML, Wang YJ, et al. China cardiovascular diseases report 2018: an updated summary. J Geriatr Cardiol 2020;17(1):1 − 8. http://dx.doi.org/10.11909/j.issn.1671-5411.2020.01.001CrossRef